  |  |
Microbes -- Friend or Foe?
Bacteria become resistant to our antibiotics. Viruses evolve with blinding speed. Prions may lurk in our meat. Anthrax is put into our mail. Stranger yet, could microbes be causing other illnesses, like cancers and heart attacks?
Participants
 | | Agnes Day, Ph.D.
Assoc. Prof. Howard University |
| | Paul Ewald , Ph.D.
Prof. Biology, U. Kentucky |
| | Alice S. Huang, Ph.D.
Microbiologist, Sr. Councilor, External Relations, Caltech |
| | Lucy Shapiro, Ph.D.
Cell biologist, Dir. Beckman Ctr. for Molecular & Genetic Med., Stanford |
|
| |
Who Gets to Validate Alternative Medicine?
Throughout history, human beings always have sought to prevent disease, cure illness, reduce pain, and relieve suffering. In recent times, science has made medicine more predictable, increasing success rates and identifying side effects to an unprecedented extent. But challenges to scientific medicine have accelerated in the past 30 years. In this program, the challenged give the challengers one tough time.
Participants
| | Hyla Cass M.D.
Psychiatrist, Integrative Medicine |
| | William Jarvis Ph.D.
Consumer Health Specialist |
| | Dan Labriola N.D.
Naturopathic Physician |
| | Wallace Sampson M.D.
Editor-in -Chief, Scientific Review of Alternative Medicine |
|
| |
Testing New Drugs: Are People Guinea Pigs?
Instituted in the sixties, clinical drug trials today have become a vast and expensive enterprise in which drug companies can spend over $100 million to bring a new molecule to market. FDA procedures are complex and elaborate as they should be, in order to bring new drugs to market quickly to help people in need, but to do good science to protect the public from a drug's potentially dangerous side effects.
Participants
| | Alexander Capron
Professor of Law & Medicine, USC |
| | Andrea Kovacs M.D.
Dir. HIV Family Clinic, USC |
| | Robert Temple M.D.
Assoc. Dir. Medical Policy, FDA |
|
|
|
|
